Combined Partial Gastrectomy,Splenectomy,and Microwave Liver Ablation of Metastatic Gastrointestinal Stromal Tumor After 4 Years of Neoadjuvant Imatinib

Abstract

Get full access to this article

View all access options for this article.

References

Miettinen

Sobin

LH.

Lasota

. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52-68.doi:10.1097/01.pas.0000146010.92933.de

http://www.ncbi.nlm.nih.gov/pubmed/15613856

Joensuu

Roberts

PJ.

Sarlomo-Rikala

et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344(14):1052-1056.doi:10.1056/NEJM200104053441404

http://www.ncbi.nlm.nih.gov/pubmed/11287975

Rutkowski

Gronchi

Hohenberger

et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937-2943.doi:10.1245/s10434-013-3013-7

http://www.ncbi.nlm.nih.gov/pubmed/23760587

Gold

JS.

Dematteo

. Neoadjuvant therapy for gastrointestinal stromal tumor (GIST): racing against resistance. Ann Surg Oncol. 2007;14(4):1247-1248.doi:10.1245/s10434-006-9291-6

http://www.ncbi.nlm.nih.gov/pubmed/17265116